tiprankstipranks
Spago Nanomedical AB (DE:7UX)
FRANKFURT:7UX
Germany Market
7UX
Spago Nanomedical AB
RESEARCH TOOLSreports

Spago Nanomedical AB (7UX) Cash flow

0 Followers

Spago Nanomedical AB Cash Flow

DE:7UX's free cash flow for Q4 2025 was kr0.00. For the 2025 fiscal year, DE:7UX's free cash flow was decreased by kr34.90M and operating cash flow was kr-6.19M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
kr -28.30Mkr -34.67Mkr -44.91Mkr -38.19Mkr -35.57M
Investing Cash Flow
kr 633.00Kkr -230.00Kkr -506.00Kkr -3.83Mkr -4.63M
Financing Cash Flow
kr 24.87Mkr 22.15Mkr 28.53Mkr 51.66Mkr 64.21M
End Cash Position
kr 29.67Mkr 32.47Mkr 45.22Mkr 62.10Mkr 52.46M
Free Cash Flow
kr 0.00kr -34.90Mkr -45.06Mkr -42.02Mkr -40.20M
Currency in SEK

Spago Nanomedical AB Cash Flow